10:11 AM EST - Spectral Medical Inc. : Provided an update following its in-person 100-Day Meeting with the U.S. Food and Drug Administration regarding the Company’s Premarket Approval application for Toraymyxin. Spectral Medical Inc.
shares T.EDT are trading down $0.01 at $1.25.
